Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARα fusion protein

Blood

Volumn 92, Issue 7, 1998, Pages 2244-2251

  Nervi, Clara ^a   Ferrara, Fabiana F ^b   Fanelli, Mirco ^b   Rippo, Maria Rita ^b   Tomassini, Barbara ^b   Ferrucci, Pier Francesco ^b   Ruthardt, Martin ^b   Gelmetti, Vania ^b   Gambacorti Passerini, Carlo ^b   Diverio, Daniela ^b   Grignani, Francesco ^b   Pelicci, Pier Giuseppe ^b   Testi, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC AGENTS; CASPASE 3; CASPASES; CELL DIFFERENTIATION; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032188989     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Grignani F, Lo Coco F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
2. Warrell RP Jr, de Thé H, Wang ZY, Degos L: Acute promyelocytic leukemia. New Engl J Med 329:177, 1993
3. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyteretinoic acid receptor oncoprotein. Cell 76:333, 1994
4. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, CarmoFonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994
5. Koken MHM, Puvio-Dutilleul F, Guillemin MC, Viron G, CruzLinares G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de Thé H: The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13:1073, 1994
6. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
7. Mangelsdorf DJ, Umesono K, Evans RM: The retinoid receptors. in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine. New York, NY, Raven, 1994, p 319
8. Kastner P, Leid M, Chambon P: Role of nuclear retinoid receptors in the regulation of gene expression, in Blomhoff R (ed): Vitamin A in Health and Disease. New York, NY, Marcel Dekker, 1994, p 189
9. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM: Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci USA 86:5854, 1989
10. Tsai S, Bartelmez S, Heyman RA, Damm K, Evans RM, Collins SJ: A mutated retinoic acid receptor-α exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258, 1992
11. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukaemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
12. Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG: Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein dimerization and RARα DNA binding domains. EMBO J 15:4949, 1996
13. Brown D, Scott K, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop M: A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 945:2551, 1997
14. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ: Altered myeloid development and acute leukemia in transgenic mice expressing PML/RARα under control of catepsin G regulatory sequences. Blood 89:376, 1997
15. He LI, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP: Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA 94:5302, 1997
16. Fenaux P, Degos L: Differentiation therapy for acute promyelocytic leukemia. New Engl J Med 337:1076, 1997
17. Degos L, Dombret H, Chomienne C, Daniel MT. Micléa JM, Chastang C, Castaigne S, Fenaux P: All-trars-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
18. Raelson JV. Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RARa oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996
19. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T: Accelerated degradation of PML-retinoic acid receptor a (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: Possible role of the proteasome pathway. Cancer Res 38:2945, 1996
20. Rosenauer A, Raelson JV, Nervi C, Eydoux P, Deblasio A, Miller WH Jr: Alteration in expression, binding to ligand and DNA. and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood 88: 2671, 1996
21. Dermine S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: The occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood 82:1573, 1993
22. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH Jr: A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAŔ mutation. Blood 89:4282, 1997
23. Boddy M, Howe K, Etkin LD, Solomon E, Freemont PS: PIC-1 a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene 13:971, 1996
24. Muller S, Matunis MJ, Dejean A: Conjugation with the ubiquitinrelated modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61, 1998
25. Sadoul R, Fernandez PA, Quiquerez AL, Martinou I, Maki M, Schroter M, Becherer JD, Irmler M, Tschopp J, Martinou JC: Involvment of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J 15:3845, 1996
26. Grimm LM, Goldberg AL, Poirer GG. Schwartz LM, Osborne BA: Proteasomes play an essential role in thymocyte apoptosis. EMBO J 15:3835, 1996
27. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 Protease Nomenclature. Cell 87:171, 1996
28. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 22:299, 1997
29. Rochette-Egly C, Lutz Y, Saunders M, Gaub MP, Chambon P: Retinoid acid receptor gamma specific immunodetection and phosphorylation. J Cell Biol 115:535, 1991
30. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci PG, Falini B: Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871, 1995
31. Beyaert R, Kidd VJ, Cornelis S, Van de Craen M, Denecker G, Lahti JM, Gururajan R, Vandeabeele P, Fiers W: Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J Biol Chem 272:11694, 1997
32. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
33. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passenni C, Adamo S, Levin AA, Pelicci PG, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARa-mediated increase of type II transglutaminase. Blood 87:1939, 1996
34. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808, 1996
35. Gallagher RE, Willman CL, Slack JL, Andersen J, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH: Association of PML-RARa fusion mRNA type with pretreatment hématologie characteristics but not treatment outcome in acute promyelocytic leukemia: An intergroup molecular study. Blood 90:1656, 1997
36. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans-retinoic acid and idarubicin (AIDA) therapy. Blood 90:1014, 1997
37. Slack JL, Yu M: Constitutive expression of the promyelocytic leukemia-associated oncogene PML-RARa in TF1 cells: Isoformspecific and retinoic acid-dependent effects on growth, bcl-2 expression, and apoptosis. Blood 91:3347, 1998
38. Bhatia M, Kirkland JB, Meckling-Gill KA: Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells. Biochem J 308:131, 1995
39. Rao L, White E: Bcl-2 and the ICE family of apoptotic regulators: Making a connection. Curr Opin Genet Dev 7:52, 1997
40. Vaux DL: CED-4. The third horseman of apoptosis. Cell 90:389, 1997
41. L Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387:773, 1997
42. Bruel A, Benoit G, De Nay D, Brown S, Lanotte M: Distinct apoptotic response in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia 9:1173, 1995
43. Park JR. Robertson K, Hickstein DD, Schickwann T, Hockenbery DM, Collins SJ: Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84:440, 1994
44. Hu ZB. Minden MD. McCulloch EA: Direct evidence for the partecipation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells. Leukemia 9:1667, 1995
45. Calbresse C, Barbey S, Venturini L, Balitrand N, Degos L, Fenaux P, Chomienne C: In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apop- totic pathways in acute promyelocytic leukemic cells. Leukemia 9:2049, 1995
46. Shao W, Fanelli M, Fenrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr: Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124, 1998
47. Zhu J, Koken MHM. Quignon F, Chelbi-AHx M, Degos L, Wang ZY, Chen Z, de The H: Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci US A 94:3978, 1997
48. Glass CK, Rose DW, Rosenfeld MG: Nuclear receptor coactivators. Curr Opin Cell Biol 9:222, 1997
49. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG: Ligand-dependent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397, 1995
50. Hong SH, David G, Wong CW, Dejean A, Privalsky ML: SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor a (RARa) and PLZF/RARα oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:9028, 1997
51. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA. Minucci S, Pelicci PG: Fusion proteins of the retinoic acid receptor-a recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815, 1998
52. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM: Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811, 1998
53. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP: Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential response to RA in APL. Nat Genet 18:126, 1998
54. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A: Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634, 1998